What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Vials

STEBAR IV

Rebeprazole 20mg

Pack: SINGLE
Format: With Carton

MRP₹75.00

A high-performance, rapid-acting proton pump inhibitor (PPI) injection formulated for the intensive management of acute acid-related gastrointestinal disorders. STEBAR IV contains Rabeprazole 20mg, providing potent and immediate inhibition of gastric acid secretion for patients requiring clinical intervention.

About The Product

Key Benefits

Rapid Onset of Antisecretory Action

Rabeprazole 20mg works by binding to and inhibiting the H+/K+-ATPase enzyme system at the secretory surface of the gastric parietal cells. It is known for its faster onset of action compared to other PPIs, providing swift relief from acute acid-related distress.

Immediate Systemic Bioavailability

The intravenous delivery bypasses the gastrointestinal tract entirely, ensuring 100% of the medication enters the bloodstream immediately. This is critical for patients who are unable to take oral medications due to vomiting, unconsciousness, or severe esophageal irritation.

Potent pH Regulation and Mucosal Healing

By blocking the final step of acid production, STEBAR IV significantly raises the intragastric pH. This creates a stable, non-acidic environment that allows for the rapid healing of gastric ulcers and erosive esophagitis.

Stable Control of Acid Reflux

The formulation provides sustained suppression of both basal and stimulated gastric acid secretion. This ensures that the patient remains protected from acid reflux and related complications for an extended period after administration.

Lower Potential for Drug Interactions

Rabeprazole is metabolized through both enzymatic (CYP450) and non-enzymatic pathways. This unique metabolic profile results in fewer drug-drug interactions, making it a safer option for hospitalized patients on complex multi-drug regimens.

Prophylaxis of Aspiration Pneumonitis

Administered pre-operatively, STEBAR IV helps to reduce the volume and acidity of gastric contents. This significantly lowers the risk of acid aspiration during anesthesia and surgical procedures.

Indication Severe Gastroesophageal Reflux Disease (GERD), Active Duodenal and Gastric Ulcers, Zollinger-Ellison Syndrome, Stress-Induced Mucosal Damage, Acute Management of Upper GI Bleeding, Pre-Surgical Acid Aspiration Prophylaxis.

Indications

Severe Gastroesophageal Reflux Disease (GERD)
Active Duodenal and Gastric Ulcers
Zollinger-Ellison Syndrome
Stress-Induced Mucosal Damage
Acute Management of Upper GI Bleeding
Pre-Surgical Acid Aspiration Prophylaxis.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

STEBAR IV